Novel Strategies for Spatiotemporal and Controlled BMP-2 Delivery in Bone Tissue Engineering
Bone morphogenetic protein-2 (BMP-2) has been commercially approved by the Food and Drug Administration for use in bone defects and diseases. BMP-2 promotes osteogenic differentiation of mesenchymal stem cells. In bone tissue engineering, BMP-2 incorporated into scaffolds can be used for stimulating...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-09-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.1177/09636897241276733 |